Zkusit zdarma
AnaptysBio, Inc.

AnaptysBio, Inc.

ANAB
Cena:
$ 59.71
-0.70 (-1.16%)
Valuace
93
Růst
83
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?

Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?

10:40 21-05-2026

Here is how AnaptysBio, Inc. (ANAB) and Electromed, Inc. (ELMD) have performed compared to their sec...

Wall Street Analysts See a 38.75% Upside in AnaptysBio (ANAB): Can the Stock Really Move This High?

Wall Street Analysts See a 38.75% Upside in AnaptysBio (ANAB): Can the Stock Really Move This High?

10:55 19-05-2026

The consensus price target hints at a 38.8% upside potential for AnaptysBio (ANAB). While empirical ...

AnaptysBio (ANAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

AnaptysBio (ANAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

10:55 14-05-2026

After losing some value lately, a hammer chart pattern has been formed for AnaptysBio (ANAB), indica...

Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update

Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update

16:15 12-05-2026

SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on ma...

Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors

Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors

9:15 11-05-2026

SAN DIEGO, May 11, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on ma...

AnaptysBio, Inc. (ANAB) is a Great Momentum Stock: Should You Buy?

AnaptysBio, Inc. (ANAB) is a Great Momentum Stock: Should You Buy?

13:01 06-05-2026

Does AnaptysBio, Inc. (ANAB) have what it takes to be a top stock pick for momentum investors? Let's...

Are Medical Stocks Lagging AnaptysBio (ANAB) This Year?

Are Medical Stocks Lagging AnaptysBio (ANAB) This Year?

10:41 05-05-2026

Here is how AnaptysBio, Inc. (ANAB) and Coherus Oncology (CHRS) have performed compared to their sec...

Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference

Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference

16:15 04-05-2026

SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on ma...

AnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

AnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

11:02 27-04-2026

AnaptysBio (ANAB) doesn't possess the right combination of the two key ingredients for a likely earn...

AnaptysBio (ANAB) Surges 14.8%: Is This an Indication of Further Gains?

AnaptysBio (ANAB) Surges 14.8%: Is This an Indication of Further Gains?

9:20 27-04-2026

AnaptysBio (ANAB) was a big mover last session on higher-than-average trading volume. The latest tre...

Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim

Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim

15:40 24-04-2026

Ruling preserves current contracted royalty rates and rejects Tesaro's request for any royalty reduc...

AnaptysBio (NASDAQ:ANAB) Director John Schmid Sells 20,645 Shares of Stock

AnaptysBio (NASDAQ:ANAB) Director John Schmid Sells 20,645 Shares of Stock

4:48 03-04-2026

AnaptysBio, Inc. (NASDAQ: ANAB - Get Free Report) Director John Schmid sold 20,645 shares of the fir...

Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update

Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update

9:00 27-03-2026

SAN DIEGO, March 27, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB) today announced that i...

Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics

Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics

9:00 27-03-2026

SAN DIEGO, March 27, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB) today announced that i...

First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement

First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement

9:00 27-03-2026

SAN DIEGO, March 27, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB) today announced that i...

AnaptysBio, Inc. (ANAB) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

AnaptysBio, Inc. (ANAB) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

11:20 10-03-2026

AnaptysBio, Inc. (ANAB) Presents at Barclays 28th Annual Global Healthcare Conference Transcript...

AnaptysBio, Inc. $ANAB Shares Sold by Citigroup Inc.

AnaptysBio, Inc. $ANAB Shares Sold by Citigroup Inc.

4:36 08-03-2026

Citigroup Inc. cut its position in shares of AnaptysBio, Inc. (NASDAQ: ANAB) by 93.3% during the und...

AnaptysBio, Inc. (ANAB) Q4 Earnings and Revenues Top Estimates

AnaptysBio, Inc. (ANAB) Q4 Earnings and Revenues Top Estimates

18:35 03-03-2026

AnaptysBio, Inc. (ANAB) came out with quarterly earnings of $1.58 per share, beating the Zacks Conse...

Anaptys Provides Update on Business Separation and Announces Fourth Quarter and Full Year 2025 Financial Results

Anaptys Provides Update on Business Separation and Announces Fourth Quarter and Full Year 2025 Financial Results

16:15 03-03-2026

Spin-off of biopharma operations into a public company to be called “First Tracks Biotherapeutics...

Anaptys Announces Participation at Upcoming Investor Conferences

Anaptys Announces Participation at Upcoming Investor Conferences

16:15 05-02-2026

SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biote...

close

ANAPTYS ANNOUNCES PARTICIPATION AT UPCOMING INVESTOR CONFERENCES

05-02-2026
SAN DIEGO, FEB. 05, 2026 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTE...
Více zde

ANAPTYS FILES MOTION TO DISMISS TESARO'S CLAIM OF ANTICIPATORY BREACH OF CONTRACT IN ONGOING LITIGATION AGAINST TESARO, A GSK SUBSIDIARY

08-01-2026
SAN DIEGO, JAN. 08, 2026 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTE...
Více zde

ANAPTYS TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

06-01-2026
SAN DIEGO, JAN. 06, 2026 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTE...
Více zde

VANDA ANNOUNCES SUBMISSION OF BIOLOGICS LICENSE APPLICATION TO THE FDA FOR IMSIDOLIMAB FOR THE TREATMENT OF GENERALIZED PUSTULAR PSORIASIS

15-12-2025
WASHINGTON , DEC. 15, 2025 /PRNEWSWIRE/ -- VANDA PHARMACEUTICALS INC. (VANDA) (NASDAQ: VNDA) TODAY ...
Více zde

ANAPTYS ANNOUNCES PARTICIPATION IN DECEMBER INVESTOR CONFERENCES

25-11-2025
SAN DIEGO, NOV. 25, 2025 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTE...
Více zde

ANAPTYS ANNOUNCES $100 MILLION STOCK REPURCHASE PLAN

21-11-2025
SAN DIEGO, NOV. 21, 2025 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTE...
Více zde

ANAPTYS INITIATES LITIGATION AGAINST TESARO, A GSK SUBSIDIARY

21-11-2025
SAN DIEGO, NOV. 21, 2025 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTE...
Více zde

ANAPTYS ANNOUNCES PHASE 2 TRIAL OF ROSNILIMAB DID NOT MEET PRIMARY OR SECONDARY ENDPOINTS AT WEEK 12 IN MODERATE-TO-SEVERE ULCERATIVE COLITIS

10-11-2025
ROSNILIMAB WAS SAFE AND WELL TOLERATED WITH SIMILAR ADVERSE EVENT RATES VS. PLACEBO OBSERVED EXPECTE...
Více zde

ANAPTYS ANNOUNCES PARTICIPATION IN NOVEMBER INVESTOR CONFERENCES

04-11-2025
SAN DIEGO, NOV. 04, 2025 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTE...
Více zde

ANAPTYS ANNOUNCES NEW POSITIVE PHASE 2B TRIAL RESULTS FOR ROSNILIMAB IN RHEUMATOID ARTHRITIS AT ACR LATE-BREAKING ORAL PRESENTATION

29-10-2025
SAN DIEGO, OCT. 29, 2025 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTE...
Více zde

ANAPTYS ANNOUNCES LATE-BREAKING ORAL PRESENTATION OF COMPLETE PHASE 2B DATA FOR ROSNILIMAB IN RHEUMATOID ARTHRITIS AT UPCOMING ACR CONVERGENCE 2025

13-10-2025
SAN DIEGO, OCT. 13, 2025 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTE...
Více zde

ANAPTYS ANNOUNCES INTENT TO SEPARATE BIOPHARMA OPERATIONS FROM SUBSTANTIAL ROYALTY ASSETS BY YEAR-END 2026

29-09-2025
SAN DIEGO, SEPT. 29, 2025 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOT...
Více zde

ANAPTYS ANNOUNCES PARTICIPATION IN SEPTEMBER INVESTOR CONFERENCES

27-08-2025
SAN DIEGO, AUG. 27, 2025 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTE...
Více zde

ANAPTYS ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

06-08-2025
SAN DIEGO, AUG. 06, 2025 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTE...
Více zde

ANAPTYS ANNOUNCES POSITIVE ROSNILIMAB DATA UPDATED THROUGH SIX MONTHS IN ROBUST PHASE 2B TRIAL IN RA

03-06-2025
SAN DIEGO, JUNE 03, 2025 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTE...
Více zde

ANAPTYS TO ANNOUNCE UPDATED DATA FROM PHASE 2B TRIAL OF ROSNILIMAB, A PD-1 DEPLETER AND AGONIST, FOR RHEUMATOID ARTHRITIS ON JUNE 3, 2025

27-05-2025
SAN DIEGO, MAY 27, 2025 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTEC...
Více zde

ANAPTYS ANNOUNCES FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

05-05-2025
SAN DIEGO, MAY 05, 2025 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTEC...
Více zde

ANAPTYS ANNOUNCES STOCK REPURCHASE PLAN

24-03-2025
SAN DIEGO, MARCH 24, 2025 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOT...
Více zde

ANAPTYS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

27-02-2025
ANNOUNCED ROSNILIMAB, A PD-1 DEPLETER AND AGONIST, ACHIEVED POSITIVE RESULTS FROM PHASE 2B RHEUMATOI...
Více zde

ANAPTYS ANNOUNCES ROSNILIMAB ACHIEVED POSITIVE RESULTS IN RA PHASE 2B TRIAL AND HIGHEST EVER REPORTED CDAI LDA RESPONSE OVER 6 MONTHS

12-02-2025
ACHIEVED STATISTICAL SIGNIFICANCE ON PRIMARY ENDPOINT AT WEEK 12 ON MEAN CHANGE FROM BASELINE DAS-28...
Více zde

ANAPTYS TO ANNOUNCE TOP-LINE DATA FROM PHASE 2B TRIAL OF ROSNILIMAB, A PD-1 DEPLETER AND AGONIST, IN RHEUMATOID ARTHRITIS ON FEB. 12, 2025

11-02-2025
SAN DIEGO, FEB. 11, 2025 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTE...
Více zde

ANAPTYS TO PRESENT AT THE GUGGENHEIM SMID CAP BIOTECH CONFERENCE

03-02-2025
SAN DIEGO, FEB. 03, 2025 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTE...
Více zde

VANDA PHARMACEUTICALS AND ANAPTYS ANNOUNCE EXCLUSIVE GLOBAL LICENSE AGREEMENT FOR VANDA TO DEVELOP AND COMMERCIALIZE IMSIDOLIMAB, AN IL-36R ANTAGONIST

03-02-2025
WASHINGTON AND SAN DIEGO, FEB. 03, 2025 (GLOBE NEWSWIRE) -- VANDA PHARMACEUTICALS INC. (VANDA) (NASD...
Více zde

ANAPTYS TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

07-01-2025
SAN DIEGO, JAN. 07, 2025 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTE...
Více zde

ANAPTYS ANNOUNCES PHASE 2B TRIAL OF ANB032, A BTLA AGONIST, DID NOT MEET PRIMARY OR SECONDARY ENDPOINTS IN ATOPIC DERMATITIS

11-12-2024
SAN DIEGO, DEC. 11, 2024 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTE...
Více zde

ANAPTYS ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

05-11-2024
SAN DIEGO, NOV. 05, 2024 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTE...
Více zde

ANAPTYS ANNOUNCES PARTICIPATION IN SEPTEMBER INVESTOR CONFERENCES

29-08-2024
SAN DIEGO, AUG. 29, 2024 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTE...
Více zde

ANAPTYS ANNOUNCES PRICING OF $100 MILLION UNDERWRITTEN REGISTERED DIRECT OFFERING

14-08-2024
LED BY LONG-STANDING INVESTOR ECOR1 CAPITAL WITH PARTICIPATION FROM ADDITIONAL EXISTING AND NEW INVE...
Více zde

ANAPTYS ANNOUNCES SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

05-08-2024
SAN DIEGO, AUG. 05, 2024 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTE...
Více zde

ANAPTYS ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

09-05-2024
SAN DIEGO, MAY 09, 2024 (GLOBE NEWSWIRE) -- ANAPTYSBIO, INC. (NASDAQ: ANAB), A CLINICAL-STAGE BIOTEC...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-09 00:00:008-KStáhnout
2025-11-26 00:00:008-KStáhnout
2025-11-21 00:00:008-KStáhnout
2025-11-10 00:00:008-KStáhnout
2025-11-04 00:00:008-KStáhnout
2025-11-04 00:00:0010-QStáhnout
2025-10-14 01:00:008-KStáhnout
2025-10-14 00:00:008-KStáhnout
2025-09-29 01:00:008-KStáhnout
2025-09-29 00:00:008-KStáhnout
2025-08-06 01:00:008-KStáhnout
2025-08-06 01:00:0010-QStáhnout
2025-08-06 00:00:008-KStáhnout
2025-08-06 00:00:0010-QStáhnout
2025-06-17 01:00:008-KStáhnout
2025-06-17 00:00:008-KStáhnout
2025-06-03 01:00:008-KStáhnout
2025-06-03 00:00:008-KStáhnout
2025-05-05 01:00:008-KStáhnout
2025-05-05 01:00:0010-QStáhnout
2025-05-05 00:00:008-KStáhnout
2025-05-05 00:00:0010-QStáhnout
2025-03-24 00:00:008-KStáhnout
2025-03-23 23:00:008-KStáhnout
2025-02-27 00:00:008-KStáhnout
2025-02-27 00:00:0010-KStáhnout
2025-02-26 23:00:008-KStáhnout
2025-02-26 23:00:0010-KStáhnout
2025-02-19 00:00:008-KStáhnout
2025-02-18 23:00:008-KStáhnout
2025-02-12 00:00:008-KStáhnout
2025-02-11 23:00:008-KStáhnout
2025-02-03 00:00:008-KStáhnout
2025-02-02 23:00:008-KStáhnout
2024-12-11 00:00:008-KStáhnout
2024-12-10 23:00:008-KStáhnout
2024-11-05 00:00:008-KStáhnout
2024-11-05 00:00:0010-QStáhnout
2024-11-04 23:00:008-KStáhnout
2024-11-04 23:00:0010-QStáhnout
2024-08-14 01:00:008-KStáhnout
2024-08-14 00:00:008-KStáhnout
2024-08-05 01:00:008-KStáhnout
2024-08-05 01:00:0010-QStáhnout
2024-08-05 00:00:008-KStáhnout
2024-08-05 00:00:0010-QStáhnout
2024-06-12 01:00:008-KStáhnout
2024-06-12 00:00:008-KStáhnout
2024-05-09 01:00:008-KStáhnout
2024-05-09 01:00:0010-QStáhnout
2024-05-09 00:00:008-KStáhnout
2024-05-09 00:00:0010-QStáhnout
2024-03-11 00:00:008-KStáhnout
2024-03-11 00:00:0010-KStáhnout
2024-03-10 23:00:008-KStáhnout
2024-03-10 23:00:0010-KStáhnout
2024-01-05 00:00:008-KStáhnout
2024-01-04 23:00:008-KStáhnout
2023-11-27 00:00:008-KStáhnout
2023-11-26 23:00:008-KStáhnout
2023-11-02 00:00:008-KStáhnout
2023-11-02 00:00:0010-QStáhnout
2023-11-01 23:00:008-KStáhnout
2023-11-01 23:00:0010-QStáhnout
2023-10-25 01:00:008-KStáhnout
2023-10-25 00:00:008-KStáhnout
2023-10-10 01:00:008-KStáhnout
2023-10-10 00:00:008-KStáhnout
2023-09-18 01:00:008-KStáhnout
2023-09-18 00:00:008-KStáhnout
2023-08-07 01:00:008-KStáhnout
2023-08-07 01:00:0010-QStáhnout
2023-08-07 00:00:008-KStáhnout
2023-08-07 00:00:0010-QStáhnout
2023-06-15 01:00:008-KStáhnout
2023-06-15 00:00:008-KStáhnout
2023-05-11 01:00:008-KStáhnout
2023-05-11 01:00:0010-QStáhnout
2023-05-11 00:00:008-KStáhnout
2023-05-11 00:00:0010-QStáhnout
2023-04-06 01:00:008-KStáhnout
2023-04-06 00:00:008-KStáhnout
2023-03-01 00:00:008-KStáhnout
2023-03-01 00:00:0010-KStáhnout
2023-02-28 23:00:008-KStáhnout
2023-02-28 23:00:0010-KStáhnout
2023-02-10 00:00:008-KStáhnout
2023-02-09 23:00:008-KStáhnout
2023-01-13 00:00:008-KStáhnout
2023-01-12 23:00:008-KStáhnout
2023-01-05 00:00:008-KStáhnout
2023-01-04 23:00:008-KStáhnout
2022-11-08 00:00:008-KStáhnout
2022-11-08 00:00:0010-QStáhnout
2022-11-07 23:00:008-KStáhnout
2022-11-07 23:00:0010-QStáhnout
2022-08-31 01:00:008-KStáhnout
2022-08-31 00:00:008-KStáhnout
2022-08-08 01:00:008-KStáhnout
2022-08-08 01:00:0010-QStáhnout
2022-08-08 00:00:008-KStáhnout
2022-08-08 00:00:0010-QStáhnout
2022-06-24 01:00:008-KStáhnout
2022-06-24 00:00:008-KStáhnout
2022-05-04 01:00:008-KStáhnout
2022-05-04 01:00:0010-QStáhnout
2022-05-04 00:00:008-KStáhnout
2022-05-04 00:00:0010-QStáhnout
2022-04-29 01:00:008-KStáhnout
2022-04-29 00:00:008-KStáhnout
2022-04-27 01:00:008-KStáhnout
2022-04-27 00:00:008-KStáhnout
2022-03-21 00:00:008-KStáhnout
2022-03-20 23:00:008-KStáhnout
2022-03-14 00:00:008-KStáhnout
2022-03-13 23:00:008-KStáhnout
2022-03-07 00:00:008-KStáhnout
2022-03-07 00:00:0010-KStáhnout
2022-03-06 23:00:008-KStáhnout
2022-03-06 23:00:0010-KStáhnout
2021-12-01 00:00:008-KStáhnout
2021-11-30 23:00:008-KStáhnout
2021-11-29 00:00:008-KStáhnout
2021-11-28 23:00:008-KStáhnout
2021-11-15 00:00:008-KStáhnout
2021-11-14 23:00:008-KStáhnout
2021-11-04 00:00:008-KStáhnout
2021-11-04 00:00:0010-QStáhnout
2021-11-03 23:00:008-KStáhnout
2021-11-03 23:00:0010-QStáhnout
2021-10-25 01:00:008-KStáhnout
2021-10-25 00:00:008-KStáhnout
2021-10-04 01:00:008-KStáhnout
2021-10-04 00:00:008-KStáhnout
2021-08-09 01:00:008-KStáhnout
2021-08-09 01:00:0010-QStáhnout
2021-08-09 00:00:008-KStáhnout
2021-08-09 00:00:0010-QStáhnout
2021-06-17 01:00:008-KStáhnout
2021-06-17 00:00:008-KStáhnout
2021-06-03 01:00:008-KStáhnout
2021-06-03 00:00:008-KStáhnout
2021-05-04 01:00:008-KStáhnout
2021-05-04 01:00:0010-QStáhnout
2021-05-04 00:00:008-KStáhnout
2021-05-04 00:00:0010-QStáhnout
2021-04-12 01:00:008-KStáhnout
2021-04-12 00:00:008-KStáhnout
2021-03-08 00:00:008-KStáhnout
2021-03-07 23:00:008-KStáhnout
2021-02-25 00:00:008-KStáhnout
2021-02-25 00:00:0010-KStáhnout
2021-02-24 23:00:008-KStáhnout
2021-02-24 23:00:0010-KStáhnout
2021-01-19 00:00:008-KStáhnout
2021-01-18 23:00:008-KStáhnout
2021-01-11 00:00:008-KStáhnout
2021-01-10 23:00:008-KStáhnout
2020-11-17 00:00:008-KStáhnout
2020-11-16 23:00:008-KStáhnout
2020-11-04 00:00:008-KStáhnout
2020-11-04 00:00:0010-QStáhnout
2020-11-03 23:00:008-KStáhnout
2020-11-03 23:00:0010-QStáhnout
2020-10-26 00:00:008-KStáhnout
2020-10-25 23:00:008-KStáhnout
2020-10-13 01:00:008-KStáhnout
2020-10-13 00:00:008-KStáhnout
2020-08-20 01:00:008-KStáhnout
2020-08-20 00:00:008-KStáhnout
2020-08-10 01:00:008-KStáhnout
2020-08-10 01:00:0010-QStáhnout
2020-08-10 00:00:008-KStáhnout
2020-08-10 00:00:0010-QStáhnout
2020-07-31 01:00:008-KStáhnout
2020-07-31 00:00:008-KStáhnout
2020-07-15 01:00:008-KStáhnout
2020-07-15 00:00:008-KStáhnout
2020-06-19 01:00:008-KStáhnout
2020-06-19 00:00:008-KStáhnout
2020-05-06 01:00:008-KStáhnout
2020-05-06 01:00:0010-QStáhnout
2020-05-06 00:00:008-KStáhnout
2020-05-06 00:00:0010-QStáhnout
2020-03-09 00:00:008-KStáhnout
2020-03-08 23:00:008-KStáhnout
2020-03-02 00:00:008-KStáhnout
2020-03-02 00:00:0010-KStáhnout
2020-03-01 23:00:008-KStáhnout
2020-03-01 23:00:0010-KStáhnout
2020-01-15 00:00:008-KStáhnout
2020-01-14 23:00:008-KStáhnout
2019-11-08 00:00:008-KStáhnout
2019-11-08 00:00:0010-QStáhnout
2019-11-07 23:00:008-KStáhnout
2019-11-07 23:00:0010-QStáhnout
2019-09-30 01:00:008-KStáhnout
2019-09-30 00:00:008-KStáhnout
2019-09-25 01:00:008-KStáhnout
2019-09-25 00:00:008-KStáhnout
2019-08-19 01:00:008-KStáhnout
2019-08-19 00:00:008-KStáhnout
2019-08-08 01:00:008-KStáhnout
2019-08-08 01:00:0010-QStáhnout
2019-08-08 00:00:008-KStáhnout
2019-08-08 00:00:0010-QStáhnout
2019-06-11 01:00:008-KStáhnout
2019-06-11 00:00:008-KStáhnout
2019-05-07 01:00:008-KStáhnout
2019-05-07 01:00:0010-QStáhnout
2019-05-07 00:00:008-KStáhnout
2019-05-07 00:00:0010-QStáhnout
2019-02-28 00:00:008-KStáhnout
2019-02-28 00:00:0010-KStáhnout
2019-02-27 23:00:008-KStáhnout
2019-02-27 23:00:0010-KStáhnout
2018-11-08 00:00:008-KStáhnout
2018-11-08 00:00:0010-QStáhnout
2018-11-07 23:00:008-KStáhnout
2018-11-07 23:00:0010-QStáhnout
2018-09-26 01:00:008-KStáhnout
2018-09-26 00:00:008-KStáhnout
2018-09-24 01:00:008-KStáhnout
2018-09-24 00:00:008-KStáhnout
2018-08-07 01:00:008-KStáhnout
2018-08-07 01:00:0010-QStáhnout
2018-08-07 00:00:008-KStáhnout
2018-08-07 00:00:0010-QStáhnout
2018-06-12 01:00:008-KStáhnout
2018-06-12 00:00:008-KStáhnout
2018-05-23 01:00:008-KStáhnout
2018-05-23 00:00:008-KStáhnout
2018-05-08 01:00:008-KStáhnout
2018-05-08 01:00:0010-QStáhnout
2018-05-08 00:00:008-KStáhnout
2018-05-08 00:00:0010-QStáhnout
2018-03-26 01:00:008-KStáhnout
2018-03-26 00:00:008-KStáhnout
2018-03-20 00:00:008-KStáhnout
2018-03-19 23:00:008-KStáhnout
2018-03-05 00:00:008-KStáhnout
2018-03-05 00:00:0010-KStáhnout
2018-03-04 23:00:008-KStáhnout
2018-03-04 23:00:0010-KStáhnout
2018-02-01 00:00:008-KStáhnout
2018-01-31 23:00:008-KStáhnout
2017-11-07 00:00:008-KStáhnout
2017-11-07 00:00:0010-QStáhnout
2017-11-06 23:00:008-KStáhnout
2017-11-06 23:00:0010-QStáhnout
2017-10-10 01:00:008-KStáhnout
2017-10-10 00:00:008-KStáhnout
2017-08-24 01:00:008-KStáhnout
2017-08-24 00:00:008-KStáhnout
2017-08-10 01:00:008-KStáhnout
2017-08-10 01:00:0010-QStáhnout
2017-08-10 00:00:008-KStáhnout
2017-08-10 00:00:0010-QStáhnout
2017-07-27 01:00:008-KStáhnout
2017-07-27 00:00:008-KStáhnout
2017-05-12 01:00:008-KStáhnout
2017-05-12 01:00:0010-QStáhnout
2017-05-12 00:00:008-KStáhnout
2017-05-12 00:00:0010-QStáhnout
2017-03-08 00:00:008-KStáhnout
2017-03-08 00:00:0010-KStáhnout
2017-03-07 23:00:008-KStáhnout
2017-03-07 23:00:0010-KStáhnout
2017-03-02 00:00:008-KStáhnout
2017-03-01 23:00:008-KStáhnout
preloader